•
Mar 31, 2014

Vaxart Q3 2014 Earnings Report

Total Revenue
$29.5M
Previous year: $12.5M
+136.0%
EPS
$0.11
Previous year: $0.00167
+6498.7%
Gross Profit
$10.2M
Previous year: $8.4M
+21.4%
Cash and Equivalents
$80.1M
Previous year: $70.3M
+13.9%
Free Cash Flow
$600K
Previous year: -$3.71M
-116.2%
Total Assets
$121M
Previous year: $94.8M
+27.1%

Vaxart

Vaxart